FDA Animal Efficacy Rule Needs To Be Codified In Bioterror Bill – Hatch
Sen. Orrin Hatch (R-Utah) is pushing for changes to the bioterrorism conference bill that would codify FDA's animal efficacy rule, he told a Food & Drug Law Institute meeting in Washington, D.C., April 15
You may also be interested in...
Industry experience should be considered an advantage for potential commissioner candidates in light of the importance of bioterrorism preparedness, Sen. Orrin Hatch (R-Utah) maintained April 16 at the Food & Drug Law Institute meeting in Washington, D.C
Antitrust exemptions for pharmaceutical companies who produce bioterrorism countermeasures is one of the last significant obstacles to moving an anti-bioterrorism authorization bill this year
The House/Senate bioterrorism conference bill may provide a vehicle for fast-track consideration of PDUFA III